Nov 20, 2023Top 10 Holdings. 2013. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). Meanwhile, XBI equal weights its holdings. For an investor to take. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. Performance and Risk The ETF has lost about -9. This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 45% and is down about -9. Its price to cash flow multiples is about 13. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. BIIB is also in the top 15 XBI holdings. Performance. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. Advertisement. XBI's top 10 holdings account for about 11. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. Some of the top XBI holdings continue to defy the bear market. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Fund Size Comparison. And, again, it is in the top 15 holdings by weighting of the biotechnology ETF,. Sector ETFs. The XBI holdings are quite variable probably helped by algos. 26 during this last 52. The company has an 88. Analysis of these related ETFs and how they are trading may provide insight to this commodity. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 2. 94 per share, with $121. 15 billion assets under management. 97. View complete XBI exchange traded fund holdings for better informed ETF trading. There is no guarantee the fund will achieve its stated investment objective. 66 +2. With about 156 holdings, it effectively. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. 35% vs 0. Both XBI and XLV are ETFs. Its fund flows were negative $259. 79 as the 52 week high point — that compares with a last trade of $76. Below is the comparison between LABU and XBI. by Sweta Killa Published on September 18,2023. 18% and is down about -39. With XBI trading at a recent price near $131. The big biotech. 71% of total assets under management. XBI currently has 133 holdings. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The firm has a market cap of $5. 7. ETFs are subject to market fluctuation and the risks of their underlying investments. 13 and $94. 93% of its total assets under management. With about 151 holdings, it effectively. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. S. Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. The weighted harmonic average of closing market price divided by. As a result, the ETF reached a new 8-month low. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). 11. 1 Day NAV Change as of Nov 09, 2023. Performance and Risk The ETF has lost about -29. 1. In XBI, the top five holdings together represent only 9. ETFs - IBB, PBE, XBI. 35%. Top 10 Holdings. So far this year, XBI has lost about -5. 38%. 35%). 01%). 15 during this last 52-week period. 22%: Revolution. XBI is an almost pure play on the biotechnology sector. 81% and is down about -5. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. argenx SE ADR. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. 0 reviews. Jun 8, 2022 10:51AM EDT. It's trading down (17%) versus LABU, down (68%) in one-year performance. 78% so far this year and in the past one year (as of 11/20/2023), respectively. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. 1% over the past year to close the last trading session at $81. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 2013. Asset type. 00%) Most Recent Dividend 0. The top holding in XBI receives just a 1. Top 10 Holdings (16. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. SPDR S&P Biotech ETF. 57 billion. Follow. XBI holdings. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. DLTR. DLTR. LABD. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. 80 per share, with $92. XBI. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. The equal weight fund, designed to deliver. 12% in the last one year (as. 17% for the trailing three-year period, which makes XBI a high. 01%). 79 as the 52 week high point — that compares with a last trade of $116. 18. 75M), Brown Advisory. 39. View the latest SPDR S&P Biotech ETF (XBI) stock price and news, and other vital information for better exchange traded fund investing. Assets Under Management. The top 10 holdings account for about 14. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. Its fund flows were negative $259. There is no guarantee the funds will achieve their stated investment objectives. Top 10 Holdings (14. 15%: Country Percentage; United States: 94. S. 12 and $91. 06 as the 52 week high point — that compares with a last trade of $109. According to data from U. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. 12% over the last 12 months (as of 07/18/2023). 04 per unit, that means that analysts see 73. SBIO holds 79 companies vs. 40 for Nov. Total healthcare and life sciences M&A was about $71. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. WIX. Performance and Risk So far this year, XBI has added roughly 1. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. •. XBI has a beta of 1. Per cent of portfolio in top 5 holdings: 8. The fund has a beta of 0. Shares of XBI stock opened at $73. 51. Expense ratio and liquidity are average for the group. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). Looking at the chart above, XBI's low point in its 52 week range is $62. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Real Estate ETFs. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. 49. Mettler-Toledo International Inc. 97. $0. Neena Mishra May 10, 2023. 44 per share, with $92. One of the ideas making the rounds on Wall Street right now (I’ve seen it commented on in a number of places) is buying XBI, the SPDR S&P Biotech ETF, at this time of year, for a spring rally. 5% position, and no other holding accounts for more than 1. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 79 as the 52 week high point — that compares with a last trade of $159. SPDR S&P Biotech ETF ETF holdings by MarketWatch. 2% weight, and there are 133 holdings in total in the fund (Figure 1). Jun 23, 2022 10:49AM EDT. XBI has traded between $62. IBB's and XBI's Top Holdings are About to Break Out. IBB has a higher expense ratio than XBI (0. 99%. 94 per share, with $121. S. As of Oct 31 2023. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 73% so far this year and is down about -39. 5x and PE ratio is about 14x. BTEK11. In XBI, the top five holdings together represent only 9. 50 -0. The fund's investments total to approximately $6. Expense ratio and liquidity are average for the group. Check out the side-by-side comparison table of XBI vs. 46% YTD Daily Total ReturnETF Summary. XBI - SPDR (R) S&P (R) Biotech ETFs top. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. ARGX. 01 to $0. Please call us for more information - (250). 28% IONS Ionis Pharmaceuticals Inc Biotechnology. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. View complete YINN exchange traded fund holdings for better informed ETF trading. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. XLY News. February 15, 2023 — 10:47 am EST. View the latest SPDR S&P Biotech ETF (XBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Holdings; Performance; Risk; Performance Overview-12. View and export this data back to 2006. XBI Holdings 5 Beaten-Down ETFs to Buy Now. Snapshot: XBI. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. The XBI has been a leader beating other ETFs YTD, up about 35% until today. 01% vs 0. The portfolio of Cathie Wood updated daily. 1% vs 0. This major support zone runs from $101. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. . *Close price adjusted for splits. 2. Company Change % Net. As of Oct 31 2023. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. 94 per share, with $107. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. The sale of ETFs is subject to an activity assessment fee (from $0. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. 5% year-to-date and 38. 08 per unit, that means that analysts see 59. The top XBI holdings:Glossary: ActiveShareis a measure of the percentage of stock holdings in a manager's portfolio that differ from the benchmark index. 5. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. 19%. 20 -4. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. 60 as the 52 week high point — that compares with a last trade of $70. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). 13%) Gold 1,980. 12% in the. 50. Free ratings, analyses, holdings, benchmarks, quotes, and news. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. XBI has a beta of 0. XBI Holdings5 Beaten-Down ETFs to Buy Now. 7% vs -5. Looking at the chart above, XBI's low point in its 52 week range is $62. Performance and Risk The ETF has lost about -29. 01%). 58% and is down about -14. 06 as the 52 week high point — that compares with a last trade of $102. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. 26 during this last 52-week period. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. 88%. This fee is shown as an annual percentage rate (APR). by Morningstar Manager Research. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Currency in USD. XBI has traded between $62. XBI: SPDR S&P Biotech ETF - Fund Holdings. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). Neena Mishra May 10, 2023. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). ETFs are subject to market fluctuation and the risks of their underlying investments. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. $5. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). XBI has traded between $73. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . Over a longer time than that, it has no top holdings. No company usually makes up more than two percent of. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI is suitable for investors seeking to. XBI is an equal-weighted ETF that follows the S&P Biotechnology Select Industry Index. 97% in the last one year (as of 11/07/2022). The top 10 holdings account for about 11. 12% in the. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. 9. Discover historical prices for XBI stock on Yahoo Finance. Fund size is a good indication of how many other investors trust this fund. Follow. Immunovant Inc. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 80% of total assets under management. 86% so far this year and is down about -32. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. Health Care Fund Highlights: 137 Total Holdings $5. 60 as the 52 week high point — that compares with a last trade of $69. 53 (+3. FA Report PDF. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The gross expense ratio is the fund’s total annual operating expenses ratio. There is no overlap of the top 10 holdings between SBIO and XBI. 98 and standard deviation of 37. Both ARKG and XBI are ETFs. 52%. Looking at the chart above, XBI's low point in its 52 week range is $63. Rated on Jun 30, 2023 Published on Jun 30. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). 1% vs 0. 47 million over the past three months. 47% vs -5. Holdings. Performance and Risk. If Moderna's share price. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. XBI holdings. The ETF return is roughly 4. 02%. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. News & World Report, XBI enjoys volume of 20. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. IBB has a higher 5-year return than XBI (0. S. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. XBI. Complete SPDR S&P Biotech ETF funds overview by Barron's. Looking at the chart above, XBI's low point in its 52 week range is $63. Performance and Risk. SPDR S&P Biotech ETF Stock Up 1. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Summary From a population of some 350 actively-traded, substantial, and growing ETFs this is a currently attractive addition to a portfolio whose principal objective is wealth accumulation by active investing. 51 on Tuesday. 33% from the latest price. 9%. In seeking to track the performance of the S&P Biotechnology Select. 96 on December 31, 2021, to $83 per share at the end of 2022. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. 80 per share, with $92. Fidelity does not endorse or adopt their content. Top 10 Holdings (14. 77% for the trailing three-year period, which makes the fund a high risk choice in the space. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. 67. Unlock comprehensive insights, track. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. The iShares Core S&P 500 ETF Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U. View Holdings As of 09/30/2023. 27. 3% over the same period: Image Source: Zacks Investment Research. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). 08%. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. 9. 81 and $97. The top holdings of these ETFs are Exact Sciences Corp. 54%. 44 per share, with $92. com. News, commentary and events are from third-party sources unaffiliated with Fidelity. 97. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. It can be found in the fund’s most recent prospectus. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Lucy Brewster | Nov 10, 2023. Holding Companies. Looking at the chart above, XBI's low point in its 52 week range is $62. These are the positions, trades, and weight of all companies in her ARKK Innovation ETF. Below is the comparison between BBC and XBI. Looking at the chart above, XBI's low point in its 52 week range is $62. 6% of the fund. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. That's the main advantage to investing. S. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public.